As the GLP-1 landscape evolves, Omada Health updates its industry FAQs to deliver timely data and insights for employers, health plans and benefit consultants. Our latest GLP-1 Guide covers the most pressing topics of Q1 - Q2 2025, including:
- New indications and their impact on employers and payers
- Early outcomes of
Omada's Enhanced GLP-1 Care Track - Survey findings from 2,000 primary care physicians on GLP-1 prescribing
Download Omada's GLP-1 Guide: New Indications, Promising Outcomes & Third-Party Prescribing to learn more
By submitting your information, you are signing up to receive offers, promotions and other commercial messages from Omada Health. You may unsubscribe from receiving these communications at any time. For more information on how we use your information, take a look at Omada's privacy policy and state privacy notice.*